Litcius/Paper detail

A comparative review of adenovirus A12 and C5 oncogenes

Luca D. Bertzbach, Wing-Hang Ip, Konstantin von Stromberg, Thomas Dobner, Roger J.A. Grand

2024Current Opinion in Virology10 citationsDOIOpen Access PDF

Abstract

Oncogenic viruses contribute to 15% of global human cancers. To achieve that, virus-encoded oncoproteins deregulate cellular transcription, antagonize common cellular pathways, and thus drive cell transformation. Notably, adenoviruses were the first human viruses proven to induce cancers in diverse animal models. Over the past decades, human adenovirus (HAdV)-mediated oncogenic transformation has been pivotal in deciphering underlying molecular mechanisms. Key adenovirus oncoproteins, encoded in early regions 1 (E1) and 4 (E4), co-ordinate these processes. Among the different adenovirus species, the most extensively studied HAdV-C5 displays lower oncogenicity than HAdV-A12. A complete understanding of the different HAdV-A12 and HAdV-C5 oncoproteins in virus-mediated cell transformation, as summarized here, is relevant for adenovirus research and offers broader insights into viral transformation and oncogenesis.

Topics & Concepts

BiologyCarcinogenesisVirologyTransformation (genetics)VirusOncovirusAdenoviridaeMalignant transformationMastadenovirusCancer researchGeneticsGeneGenetic enhancementVirus-based gene therapy researchCAR-T cell therapy researchRNA Interference and Gene Delivery
A comparative review of adenovirus A12 and C5 oncogenes | Litcius